Cancer Genetics Cancer Research

Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →